TallyHQ
github
Client · LDA

VIATRIS INC

5 filings 18 bills mentioned 1 registrants 5 quarters ~$2,800,000 reported
Client ID
134178

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 1302
Increasing Transparency in Generic Drug Applications Act
HCR
5
S 891
Bipartisan Health Care Act
HCR
5
HR 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HCR
5
HR 4132
Prescription Information Modernization Act of 2025
HCR
4
S 1553
PREVAIL Act
CPT
4
—
119:hr:9747
BUD
4
S 2296
National Defense Authorization Act for Fiscal Year 2026
DEF
4
S 2027
Prescription Information Modernization Act of 2025
HCR
4
S 2658
Medication Affordability and Patent Integrity Act
HCR
3
S 2129
SAFE Tax Filing Act of 2025
HCR
1
S 2916
Long-Distance Corridor Relief Act
HCR
1
S 3778
Carbon Resource Innovation Act
TRD
1
HR 1503
Stop Forced Organ Harvesting Act of 2025
HCR
1
S 2220
Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans Act of 2025
CPT
1
S 775
SAFE Act of 2025
HCR
1
S 3841
Last Sale Valuation Act of 2026
TRD
1
—
119:s:4638
DEF
1
HR 5461
Special Diabetes Program Reauthorization Act of 2025
HCR
1

Registrants

Lobbying firms that filed on behalf of this client.

VIATRIS INC. 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.